The evaluation of antimicrobial susceptibility of urine enterococci with the Vitek 2 automated system in Eastern Turkey

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 43, Issue 4, 2012, Pages 986-991

  Sibel, A K ^a   Mehmet, Köroglu ^a   Muharrem, A K ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Antimicrobial susceptibility; Enterococcus spp; HLAR; Urinary tract infection; Vitek 2

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; ENTEROCOCCUS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; TURKEY (REPUBLIC); URINALYSIS; URINARY TRACT INFECTION; URINE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; HUMANS; TURKEY; URINALYSIS; URINARY TRACT INFECTIONS; URINE;

EID: 84868608762     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Adhikari L. High level aminoglycoside resistance and reduced susceptibility to vancomycin in nosocomial enterococci. J Glob Infect Dis 2010; 2: 231-5.
2. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993; 37: 1563-71.
3. Barros M, Martinelli R, Rocha H. Enterococcal urinary tract infections in a university hospital: Clinical studies. Braz J Infect Dis 2009; 13: 294-6.
4. Bratcher DF. Vancomycin-resistant enterococci in the pediatric patient. Pediatr Infect Dis J 2001; 20: 621-2.
5. Brown DFJ, Brown NM, Cookson B, et al. National glycopeptide-resistant enterococcal bacteraemia surveillance Working Group report to the Department of Health - August 2004. J Hosp Infect 2006; 62 (suppl 1): 1-27.
6. Brown SD, Traczewski M, Cookson B, et al. Comparative In vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. J Clin Microbiol 2007; 45: 2173-9.
7. Çetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686-707.
8. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Eighteenth informational supplement. Document M100-S18. Wayne: CLSI, 2008.
9. Courvalin P. Vancomycin resistance in Gram-positive cocci. Clin Infect Dis 2006; 42 (suppl 1): S25-34.
10. Daza R, Gutiérrez J, Piédrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents 2001; 18: 211-5.
11. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2007; 58: 163-70.
12. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997. Antonie Van Leeuwenhoek 2000; 77: 147-52.
13. Franz CMAP, Holzapfel WH, Stiles ME. Enterococci at the crossroads of food safety. Int J Food Microbiol 1999; 47: 1-24.
14. Kaçmaz B, Aksoy A. Antimicrobial resistance of enterococci in Turkey. Int J Antimicrob Agents 2005; 25: 535-8.
15. Koeijers JJ, Verbon A, Kessels AGH, et al. Urinary tract infection in male general practice patients: Uropathogens and antibiotic susceptibility. Urology 2010; 76: 336-40.
16. Kucheria R, Dasgupta P, Sacks SH, et al. Urinary tract infections: new insights into a common problem. Postgrad Med J 2005; 81: 83-6.
17. Patterson JE, Sweeney AH, Simms M, et al. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 1995; 74: 191-200.
18. Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J Hosp Infect 2010; 75: 225-7.
19. Rudy M, Nowakowska M, WiechuBa B, Zientara M, Radosz-Komoniewska H. Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine. Przegl Lek 2004; 61: 473-6.
20. Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ. Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 1990; 28: 435-7.
21. Thomson Jr RB. Specimen collection, transport and processing: bacteriology. In: Murray P, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual of clinical microbiology. Vol 1. 9th ed. Washington, DC: American Society for Microbiology, 2007: 291-333.
22. Turnidge J, Bell J, Biedenbach DJ, Jones RN. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998/1999. Int J Antimicrob Agents 2002; 20: 10-7.
23. Winn JW, Allen S, Janda W, et al. Koneman's color atlas and textbook of diagnostic microbiology. 6th ed. Chapter 13. Gram positive cocci. Philadelphia: Leppicott Williams & Wilkins, 2006: 672-764.
24. Wisell KT, Kahlmeter G, Giske CG. Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue. J Antimicrob Chemother 2008; 62: 35-40.